NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
10.71
-0.23 (-2.10%)
At close: Jun 27, 2025, 4:00 PM
11.12
+0.41 (3.83%)
After-hours: Jun 27, 2025, 7:39 PM EDT
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $351.27 million as of June 27, 2025. Its market cap has increased by 89.90% in one year.
Market Cap
351.27M
Enterprise Value
358.16M
1-Year Change
89.90%
Ranking
Category
Stock Price
$10.71
Market Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has decreased from $393.28M to $351.27M, a decrease of -10.68%. That is a compound annual growth rate of -2.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 358.82M | 7.43% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |